Effort required to contact primary care providers after newborn screening identifies sickle cell trait

Journal of the National Medical Association

Volumn 104, Issue 11-12, 2012, Pages 528-534

  Christopher, Stephanie A ^a   Collins, Jenelle L ^a   Farrell, Michael H ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Genetics; Newborn screening; Patient provider communication; Sickle cell disease

Indexed keywords

ARTICLE; GENETIC ANALYSIS; HEALTH CARE PERSONNEL; HEALTH SERVICE; HUMAN; INFANCY; INFANT; INTERNET; MAJOR CLINICAL STUDY; MEDICAID; MEDICAL PRACTICE; NEWBORN SCREENING; POPULATION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SICKLE CELL TRAIT;

EID: 84876186525     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-9684(15)30219-4     Document Type: Article

References (42)

1. Pass K, Harris K, Lorey F, Choi R, Kling S. Update: newborn screening for sickle cell disease-California, Illinois, and New York, 1998. MMWR. 2000;49(32):729-731.
2. Farrell PM, Lai HJ, Li Z, et al. Evidence on improved outcomes with early diagnosis of cystic fibrosis through neonatal screening: enough is enough! J Pediatr. 2005;147(3 suppl):S30-S36. (Pubitemid 41400256)
3. Farrell MH, Christopher SA, Tluczek A, et al. Improving communication between doctors and patients after newborn screening. Wisc Med J. 2011;110(5):221-227.
4. Abhyankar S, Lloyd-Puryear MA, Goodwin R, et al. Standardizing newborn screening results for health information exchange. Paper presented at American Medical Informatics Association 2010 Symposium; Washington DC.
5. Desposito F, Lloyd-Puryear MA, Tonniges TF, Rhein F, Mann M. Survey of pediatrician practices in retrieving statewide authorized newborn screening results. Pediatrics. 2001;108(2):E22.
6. Tsaras G, Owusu-Ansah A, Boateng FO, Amoateng-Adjepong Y. Complications associated with sickle cell trait: a brief narrative review. Am J Med. 2009;122(6):507-512.
7. Ashcroft M, Miall W, Milner P. A comparison between the characteristics of Jamaican adults with normal hemoglobin and those with sickle cell trait. Am J Epidemiol. 1969;90(3):236.
8. Tuck S, Studd J, White J. Pregnancy in sickle cell disease in the UK. Br J Obstet Gynaecol. 1983;90(2):112.
9. Hakimi A, Koi P, Milhoua P, et al. Renal medullary carcinoma: the Bronx experience. Urology. 2007;70(5):878.
10. Bruno D, Wigfall D, Zimmerman S, Rosoff P, Wiener J. Genitourinary complications of sickle cell disease. J Urol. 2001;166(3):803.
11. Austin H, Key N, Benson J, et al. Sickle cell trait and the risk of venous thromboembolism. Blood. 2007;110(3):908.
12. Bennett N, Mulhall J. Sickle cell disease status and outcomes of African-American men presenting with priapism. J Sex Med. 2008;5(5):1244.
13. Tita A, Biggio J, Chapman V, Neely C, Rouse D. Perinatal and maternal outcomes in women with sickle or hemoglobin C trait. Obstet Gynecol. 2007;110(5):1113.
14. Anzalone ML, Green VS, Buja M, Sanchez LA, Harrykissoon RI, Eichner ER. Sickle cell trait and fatal rhabdomyolysis in football training: a case study. Med Sci Sports Exerc. 2010;42(1):3-7.
15. Kark JA, Posey DM, Schumacher HR, Ruehle CJ. Sickle-cell trait as a risk factor for sudden death in physical training. N Engl J Med. 1987;317(13):781- 787. (Pubitemid 17133357)
16. Thogmartin JR, Wilson CI, Palma NA, Ignacio SS, Shuman MJ, Flannagan LM. Sickle Cell Trait-Associated Deaths: A Case Series with a Review of the Literature. J. Forensic Sci. 2011;56(5):1352-1360.
17. Scoville SL, Gardner JW, Magill AJ, Potter RN, Kark JA. Nontraumatic deaths during US Armed Forces basic training, 1977-2001. Am J Prev Med. 2004;26(3):205-212. (Pubitemid 38338669)
18. Hosick MB. Protocol decided for sickle cell testing. The NCAA News. April 13, 2010.
19. Stein R. Colleges mandate sickle cell testing. Washington Post. September 20, 2010; A05.
20. Thomas K, Zarda B. In NCAA, question of bias over a test for a genetic trait. The New York Times. April 12, 2010; D1.
21. Uddin DE, Dickson LG, Brodine CE. Screening of military recruits for hemoglobin variants. JAMA. 1974;227(12):1405-1407.
22. Scoville SL. Chapter 25: Recruit Mortality. Recruit Medicine. Washington, DC: Office of The Surgeon General, US Army, Borden Institute Walter Reed Army Medical Center; 2006.
23. Davis DS. Discovery of children's carrier status for recessive genetic disease: some ethical issues. Genetic Testing. 1998;2(4):323-327. (Pubitemid 128538137)
24. Nelson RM, Botkin JR, Kodish ED, et al. Ethical issues with genetic testing in pediatrics. Pediatrics. 2001;107(6):1451-1455. (Pubitemid 32525235)
25. Gallo AM, Wilkie D, Suarez M, et al. Reproductive decisions in people with sickle cell disease or sickle cell trait. West J Nurs Res. 2010;32(8):1073-1090.
26. Asgharian A, Anie KA. Women with sickle cell trait: reproductive decision-making. J Reprod Infant Psychol. 2003;21(1):23-34.
27. Oliver S, Dezateux C, Kavanagh J, Lempert T, Stewart R. Disclosing to parents newborn carrier status identified by routine blood spot screening. Cochrane Database Syst Rev. 2004(4):CD003859.
28. Miller FA, Hayeems RZ, Bombard Y, et al. Clinical obligations and public health programmes: healthcare provider reasoning about managing the incidental results of newborn screening. J Med Ethics. 2009;35:626-634.
29. Laird L, Dezateux C, Anionwu EN. Neonatal screening for sickle cell disorders: what about the carrier infants? BMJ. 1996;313(7054):407-411. (Pubitemid 26289982)
30. Kai J, Ulph F, Cullinan T, Qureshi N. Communication of carrier status information following universal newborn screening for sickle cell disorders and cystic fibrosis: qualitative study of experience and practice. Health Technol Assess. 2009;13(57):1-82, iii.
31. Miller FA, Paynter M, Hayeems RZ, et al. Understanding sickle cell carrier status identified through newborn screening: a qualitative study. Eur J Hum Genet. 2010;18(3):303-308.
32. Markel H. The stigma of disease: implications of genetic screening. Am J Med. 1992;93(2):209-215.
33. McNeil TF, Harty B, Thelin T, Aspegren-Jansson E, Sveger T. Identifying children at high somatic risk: long-term effects on mother- child interaction. Acta Psychiatr Scand. 1986;74(6):555-562. (Pubitemid 17225924)
34. Farrell MH, Certain L, Farrell PM. Genetic counseling and risk communication services of newborn screening programs. Arch Ped Adol Med. 2001;155(2):120-126. (Pubitemid 32128379)
35. Miller FA, Robert JS, Hayeems RZ. Questioning the consensus: managing carrier status results generated by newborn screening. Am J Public Health. 2009;99(2):210-215.
36. National Newborn Screening and Genetics Resource Center. National Newborn Screening Information System 2008 report and ongoing reports from 2010. 2010; http://nnsis.uthscsa.edu/xreports.aspx?XREPORTID=5. Accessed July 28, 2011.
37. Kavanagh PL, Wang CJ, Therrell BL, Sprinz PG, Bauchner H. Communication of positive newborn screening results for sickle cell disease and sickle cell trait: variation across states. Am J Med Genet C Semin Med Genet. 2008;148C(1):15-22. (Pubitemid 351294848)
38. Kim S, Lloyd-Puryear MA, Tonniges TF. Examination of communication practices between state newborn screening programs and the medical home. Pediatrics. 2003;111(2):e120-e126.
39. Georgia Department of Public Health. Newborn screening for metabolic and sickle cell disorders program. 2011. http://health.state. ga.us/programs/nsmscd/ diag-hemoglobin.asp. Accessed July 28, 2011.
40. Bales A, Zaleski C, McPherson E. Newborn screening programs: Should 22q11 deletion syndrome be added? Genet Med. 2010;12(3):135-144.
41. Day SW, Brunson GE, Wang WC. Successful newborn sickle cell trait counseling program using health department nurses. Pediatr Nurs. 1997;23(6):557-561.
42. La Pean A, Collins JL, Christopher SA, et al. A Qualitative Secondary Evaluation of Statewide Follow-Up Interviews for Abnormal Newborn Screening Results for Cystic Fibrosis and Sickle Cell Hemoglobinopathy. Genet Med. 2012;14(2): 207-214.